Abstract

The aim of the study was to examine the effect of previous pregnancies and classical cardiovascular risk factors on vascular endothelial function in a group of 264 young and middle-aged women 3 to 11 years postpartum. We examined microvascular functions by peripheral arterial tonometry and EndoPAT 2000 device with respect to a history of gestational hypertension, preeclampsia, fetal growth restriction, the severity of the disease with regard to the degree of clinical signs and delivery date. Besides, we compared Reactive Hyperemia Index (RHI) values and the prevalence of vascular endothelial dysfunction among the groups of women with normal and abnormal values of BMI, waist circumference, systolic and diastolic blood pressures, heart rate, total serum cholesterol levels, serum high-density lipoprotein cholesterol levels, serum low-density lipoprotein cholesterol levels, serum triglycerides levels, serum lipoprotein A levels, serum C-reactive protein levels, serum uric acid levels, and plasma homocysteine levels. Furthermore, we determined the effect of total number of pregnancies and total parity per woman, infertility and blood pressure treatment, presence of trombophilic gene mutations, current smoking of cigarettes, and current hormonal contraceptive use on the vascular endothelial function. We also examined the association between the vascular endothelial function and postpartum whole peripheral blood expression of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases (miR-1-3p, miR-16-5p, miR-17-5p, miR-20a-5p, miR-20b-5p, miR-21-5p, miR-23a-3p, miR-24-3p, miR-26a-5p, miR-29a-3p, miR-92a-3p, miR-100-5p, miR-103a-3p, miR-125b-5p, miR-126-3p, miR-130b-3p, miR-133a-3p, miR-143-3p, miR-145-5p, miR-146a-5p, miR-155-5p, miR-181a-5p, miR-195-5p, miR-199a-5p, miR-210-3p, miR-221-3p, miR-342-3p, miR-499a-5p, and miR-574-3p). A proportion of overweight women (17.94% and 20.59%) and women with central obesity (18.64% and 21.19%) had significantly lower RHI values at 10.0% false positive rate (FPR) both before and after adjustment of the data for the age of patients. At 10.0% FPR, a proportion of women with vascular endothelial dysfunction (RHI ≤ 1.67) was identified to have up-regulated expression profile of miR-1-3p (11.76%), miR-23a-3p (17.65%), and miR-499a-5p (18.82%) in whole peripheral blood. RHI values also negatively correlated with expression of miR-1-3p, miR-23a-3p, and miR-499a-5p in whole peripheral blood. Otherwise, no significant impact of other studied factors on vascular endothelial function was found. We suppose that screening of these particular microRNAs associated with vascular endothelial dysfunction may help to stratify a highly risky group of young and middle-aged women that would benefit from early implementation of primary prevention strategies. Nevertheless, it is obvious, that vascular endothelial dysfunction is just one out of multiple cardiovascular risk factors which has only a partial impact on abnormal expression of cardiovascular and cerebrovascular disease associated microRNAs in whole peripheral blood of young and middle-aged women.

Highlights

  • We studied the effect of multiple factors such as the blood pressure treatment, the presence of trombophilic gene mutations, body mass index (BMI), waist circumference, SBP, DBP, heart rate, total serum cholesterol levels, serum high-density lipoprotein (HDL) cholesterol levels, serum low-density lipoprotein (LDL) cholesterol levels, serum triglycerides levels, serum Lp(a) levels, serum C-reactive protein (CRP) levels, serum uric acid levels, and plasma homocysteine levels on the vascular endothelial function via comparison of Reactive Hyperemia Index (RHI) values and the prevalence of vascular endothelial dysfunction among the groups of women with normal and abnormal clinical findings

  • We suppose that screening of these particular microRNAs associated with vascular endothelial dysfunction may help to stratify a highly risky group of young and middle-aged women that would benefit from early implementation of primary prevention strategies

  • It is apparent that at least the lower RHI values occur more frequently in young and middle-aged women with higher BMI and central obesity, which are both considered as risk factors of later development of cardiovascular diseases

Read more

Summary

Introduction

Pregnancy-related complications such as gestational hypertension (GH), preeclampsia (PE), and fetal growth restriction (FGR) are associated with the risk of later development of diabetes mellitus [1,2,3,4,5,6], metabolic syndrome [7,8], hypertension [3,4,5,6,9,10,11,12], kidney diseases [4], atherosclerosis [13,14], ischemic heart disease [4,9,10,15,16,17,18,19], myocardial infarcts [4,5,6,11,16,17], heart failure [4,5,6,11], stroke [4,5,6,9,10,11,15,16,17,19], and deep venous thrombosis [3,9,10].Few studies have been performed to explore postpartum vascular changes in young and middle-aged women with respect to a comprehensive history of pregnancy [20,21,22,23]. We examined microvascular functions (peripheral endothelium) in women with a prior onset of pregnancy-related complications (gestational hypertension, preeclampsia, and fetal growth restriction), and compared them with controls, women with a history of normally progressing pregnancies, matched for age and time elapsed since delivery (3 to 11 years). We compared Reactive Hyperemia Index (RHI) values and the prevalence of vascular endothelial dysfunction among the groups of women with normal and abnormal values of BMI, waist circumference, systolic (SBP) and diastolic (DBP) blood pressures, heart rate, total serum cholesterol levels, serum HDL (high-density lipoprotein) cholesterol levels, serum LDL (low-density lipoprotein) cholesterol levels, serum triglycerides levels, serum lipoprotein A Lp(a) levels, serum CRP (C-reactive protein) levels, serum uric acid levels, and plasma homocysteine levels. We determine the effect of the blood pressure treatment, the presence of trombophilic gene mutations, current smoking of cigarettes, and current hormonal contraceptive use on the vascular endothelial function

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.